AKEBIA THERAPEUTICS
Akebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme. Akebia Therapeutics, Inc. was founded in 2007 and is based in Cincinnati, Ohio.
AKEBIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.akebia.com
Total Employee:
11+
Status:
Active
Contact:
(617) 871-2098
Email Addresses:
[email protected]
Total Funding:
340.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adagio Medical
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akarna Therapeutics
At Akarna, our mission is to develop best-in-class treatments for NASH and other chronic liver diseases
Allinaire Therapeutics
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.
Anavex
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Arsenal Medical
Arsenal Medical develops novel products that improve local therapy for injuries and diseases.
Atara Biotherapeutics
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
BIOMx
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Neuropore Therapies
San Diego-based Neuropore, a biopharmaceuticals firm developing treatments for Parkinson's disease.
NovaDigm Therapeutics
NovaDigm Therapeutics develops vaccines that protect patients from contracting fungal and bacterial infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-06-28 | Keryx Biopharmaceuticals | Keryx Biopharmaceuticals acquired by Akebia Therapeutics | N/A |
Investors List
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Akebia Therapeutics
Orchard Venture Partners
Orchard Venture Partners investment in Series C - Akebia Therapeutics
Kearny Venture Partners
Kearny Venture Partners investment in Series C - Akebia Therapeutics
Athenian Venture Partners
Athenian Venture Partners investment in Series C - Akebia Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Akebia Therapeutics
Satter Investment Management
Satter Investment Management investment in Series C - Akebia Therapeutics
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series C - Akebia Therapeutics
Novo Holdings
Novo Holdings investment in Series C - Akebia Therapeutics
AgeChem Venture Fund
AgeChem Venture Fund investment in Series C - Akebia Therapeutics
Venture Investors
Venture Investors investment in Series C - Akebia Therapeutics
Official Site Inspections
http://www.akebia.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.89 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
